View in EDS

Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection.

Saved in:
Bibliographic Details
Title: Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection.
Authors: Meena P; Department of Nephrology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India., Crew RJ; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
Source: Kidney international reports [Kidney Int Rep] 2022 May; Vol. 7 (5), pp. 937-938. Date of Electronic Publication: 2022 Mar 12.
Publication Type: Editorial; Comment
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101684752 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-0249 (Electronic) Linking ISSN: 24680249 NLM ISO Abbreviation: Kidney Int Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35309736
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Meena+P%22">Meena P</searchLink>; Department of Nephrology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.<br /><searchLink fieldCode="AU" term="%22Crew+RJ%22">Crew RJ</searchLink>; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101684752%22">Kidney international reports</searchLink> [Kidney Int Rep] 2022 May; Vol. 7 (5), pp. 937-938. <i>Date of Electronic Publication: </i>2022 Mar 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101684752 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2468-0249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224680249%22">24680249 </searchLink><i>NLM ISO Abbreviation: </i>Kidney Int Rep <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35309736
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ekir.2022.03.005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 937
    Titles:
      – TitleFull: Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Meena P
      – PersonEntity:
          Name:
            NameFull: Crew RJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2022 May
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2468-0249
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Kidney international reports
              Type: main
ResultId 1